EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation



Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation



Official Gazette of the United States Patent & Trademark Office Patents 1268(3), Mar 18



The present invention provides substituted 11-phenyl-dibenzazepine compounds that are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

(PDF emailed within 1 workday: $29.90)

Accession: 035790544

Download citation: RISBibTeXText



Related references

Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation. Official Gazette of the United States Patent & Trademark Office Patents 1231(4), Feb 22, 2000

Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation. Official Gazette of the United States Patent & Trademark Office Patents 1232(4), Mar 28, 2000

11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents. Bioorganic & Medicinal Chemistry Letters 19(1): 104-107, 2008

Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours. Official Gazette of the United States Patent & Trademark Office Patents 1250(3), Sep 18, 2001

Drug treatment of diseases characterized by abnormal movements. Proceedings of the Royal Society of Medicine 66(9): 871-873, 1973

Composition and method containing products extracted from Commiphora sp for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease. Official Gazette of the United States Patent & Trademark Office Patents 1261(3), Aug 20, 2002

Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death. Official Gazette of the United States Patent & Trademark Office Patents 1217(3): 2469, Dec 15, 1998

Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens. 2007

Fourteen compounds and their derivatives for the treatment of diseases and injuries characterized by reduced neurogenesis and neurodegeneration. Neuronascent, Inc.: WO2007035722. Expert Opinion on Therapeutic Patents 19(4): 541-547, 2009

Effect of vitamin A on epithelial cells of skin. The use of vitamin A in the treatment of diseases characterized by abnormal keratinization. Archives of Dermatology 87: 63-80, 1963

Metal-induced coordination inversion and carbon-nitrogen bond rearrangement. Structurally characterized phenyl isocyanate inserted into aluminum methyl compounds and O- and N-bound aluminum compounds. Inorganic Chemistry 43(6): 2183-2188, 2004

Clinical trial of ilidar; a new dibenzazepine adrenergic blocking drug, in the treatment of peripheral vascular diseases and miscellaneous complaints. Circulation 10(3): 374-383, 1954

Use of 2-mercaptoethanolamine and related aminothiol compounds and copper -3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases. Official Gazette of the United States Patent & Trademark Office Patents 1248(2), July 10, 2001

Dibenzazepine compounds. Progress and use. Dental Digest 77(9): 535-536, 1971

Identification of compounds for the treatment or prevention of proliferative diseases. Official Gazette of the United States Patent & Trademark Office Patents 1275(1), Oct 7, 2003